CAR T-cell therapy in Ramat Gan typically costs from $365,000 to $525,000. Prices depend on the specific cancer type and whether the treatment uses commercial or hospital-developed cell protocols. Patients save around 84% compared to the US, where this procedure costs $525,000 on average. Packages generally include cell collection, genetic engineering, chemotherapy, and a 21-day hospital stay.
- Hospital-developed protocols: Generally offer more competitive pricing than using brand-name commercial CAR-T products.
- Pediatric programs: Usually involve extensive specialist consultations across oncology, hematology, and immunology departments.
- In-patient monitoring: Prices include approximately three weeks of hospitalization for side-effect management and safety.
- Diagnostic bundles: Includes PET/CT, MRI, biopsies, and comprehensive cancer marker analysis for precise monitoring.
Bookimed Expert Insight: Ramat Gan is Israel's primary hub for cellular immunotherapy, concentrating higher volumes of CAR-T cases than other domestic centers. Clinics like Sheba Medical Center, ranked 7th globally by Newsweek, offer researchers-led programs that integrate "home-grown" cell production. This internal manufacturing allows specialists like Dr. Elad Jacoby, who pioneered CAR-T in Israel, to provide personalized protocols without the logistical markups of commercial products.